![logo](/logos/LNTH.webp)
Lantheus Holdings, Inc.
NASDAQ:LNTH
101.98 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Lantheus Holdings, Inc. |
Symbool | LNTH |
Munteenheid | USD |
Prijs | 101.98 |
Beurswaarde | 7,080,532,588 |
Dividendpercentage | 0% |
52-weken bereik | 50.2 - 126.89 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Mary Anne Heino |
Website | https://www.lantheus.com |
An error occurred while fetching data.
Over Lantheus Holdings, Inc.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)